1/32
Looks like no tags are added yet.
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—Lewis
Antigen expression
Not synthesized by the RBCs but are adsorbed onto the RBC from the plasma
Addition of a single fucose molecule
Found in secretions, not in A,B, or H antigens in Le (a+b-)
Leb has 2 fucose molecules
Antibody expression
More commonly detected
Usually IgM, reacts at RT, clinically insignificant
Cannot cross placenta
Leb is less common compared to Lea
Unique characteristics
3 phenotypes
Le (a+b+) is not possible
Lewis expression depends on secretor gene
In saliva and bodily fluids
Diseases associated
Cholera
ETEC E.coli
Rare HDN
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—P
Antigen expression
P1, p, Pk
p has no antigens on RBCs
Antibody expression
IgM, naturally occurring, clinically insignificant
Reactivity neutralized by hydatid cyst fluid
p causes spontaneous abortions
Unique characteristics
P2 reacts weak at low temps
P1 has no corresponding serum antibodies
P1 is highly prevalent
p is a very rare phenotype
p antigens appear in WBCs, PLTs, epi cells
Disease associations
P1—PCH, UTIs, P. aeruginosa binding site
P2—PCH, Parvovirus B19
p—Shigella toxin, HUS
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—I
Antigen expression
Adult RBCs are generally I+
Infants become I+ over the first 18 months of age
i are cord blood RBCs
Rare adult RBCs are i-positive
Antibody expression
I—IgM autoantibody, often detected at RT, phase is specimen is cold
May be pathologic and the autoantibody associated with CAD and M. pneumoniae infections
i—Less common IgM autoantibody
Unique characteristics
I—cold reactive antibody
i—resists common enzymes, rare adult i phenotype
Associated disease states
I—CAD, Thalassemia, Diamond Blackfan anemia
i—Mono, Hodgkin lymphoma
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—MNS
Antigen expression
M & N— both demonstrate dosage & are destroyed by enzymes
S/s—carried by GPB, very rare
U—high prevalence antigen, lacked by 2% of black pop.
Antibody expression
M & N— IgM, naturally occurring, react at RT, M is clinically insignificant, some anti-M react at 37°C and AHG
N does not react at AHG
S/s—IgG, immune in origin, clinically significant, do not react at RT, reacts with AHG
U—Same as S/s
Unique characteristics
M—Codominant to N, Dosage effect (M+, N-), proteolytic enzymes destroy M
N—different amino acid structure makes it different than M
S—Codominant allelle to S, clinically significant antibody
s—more common across populations
U—if U is negative, S/s are also negative, resists common enzymes
Disease association
M & N—HDFN
S/s—Chagas disease, Severe HDFN
U—HDFN, HTR
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—Rh
Antigen expression
D—Most likely to cause immune response if introduced to one who lacks it, determines is blood type is ±
C/c—RhCe codes for C antigen, can rarely have antigen G (only for C), f antigen is rare in (c antigen)
E—less common in individuals
e—more common in individuals
Antibody expression
D—IgG, targets D antigen on RBC, doesn’t react at RT, reacts with AHG, highly prevalent
C—same as D, targets C antigen, need C - RBCs
c—Same as D, very prevalent
E—alloantibody, less common, can cross placenta
e—very prevalent, e- donors are hard to find
Unique characteristics
D—Not present without prior exposure to D+, determines blood type, most immunogenic
C—originally blood group O, Cw antigen is very rare
c— 2nd most clinically significant Rh antibody
E—Less common than other Rh antigens, inherited with c antibody
e—ability to trigger immune response due to low immunogenicity
Disease Associations
D—HDFN, HTR, HIV, Hep B
C—HDFN, Hep. C
c—HDN/HTR
E—HDFN, Sickle cell disease
e—HDFN, HTR, Ulcers
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—Kell
Antigen expression
K—low prevalence antigen present on approx. 9% of the pop., 32 identified antigens, only 2 screened routinely
k—High prevalence antigen on 99.8% of the pop.
Antibody expression
K/k—IgG, immune mediated, react at 37°C/AHG, most often identified alloantibody behind D in immunogenicity
Unique characteristics
K—small minority carry the K antigen
k—Found in 90% of people, cause severe transfusion reactions
Disease associations
K—HDFN, IHTR, McLeod Syndrome, CGD
k—X-CGD, McLeod Syndrome, HTR
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—Duffy
Antigen expression
Destroyed by enzyme & demonstrate dosage
Duffy Fya—65% prevalence in whites, only 10% in blacks
Duffy Fyb is less prevalent
Antibody expression
Fya—Low prevalence antibody, IgG immune mediated, react at 37°C/AHG
Fyb—Higher prevalence
Unique characteristics
Offers partial protection against clinical vivax malaria
Found on endothelial cells lining blood vessels
Easily destroyed by proteolytic enzymes
Associated disease states
IHTR
DHTR
Malaria
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—Kidd
Antigen expression
Jka is highly prevalent
Jkb is less prevalent
Antibody expression
Jka IgG, immune mediated, react at 37°C/AHG
More frequent, not common, bind complement & may be dependent upon complement detectiomn
Jkb Less frequent, not common, same class as Jka
Unique characteristics
Jka is well established at birth, concentrates urea
Jkb is a low prevalence antigen, poorly developed at birth, contains HLA antibodies
Associated disease states
Jka—DHTR, AHTR, HDFN
Jkb—HDFN (rare), Fetal anemia
Explain antigen/antibody expression for the following blood group systems, give any unique characteristics or associated disease states—Lutheran
Antigen expression
Lua—Low prevalence antigen, Not fully developed at birth, Destroyed by trypsin & chymotrypsin, resistant to ficin and papain
Lub—High prevalence antigen, destroyed by trypsin, resistant to ficin & papain, varies in strength
Antibody expression
Lua—IgM, reacts at RT, not with AHG, Naturally occuring
Lub—IgG, do not react at RT, react at AHG, naturally occuring
Unique characteristics
Lua—Low prevalence antigen, poorly developed at birth, contains HLA antibodies
Lub—High prevalence RBC antigen, immune antibody
Associated disease states
Lua—HDFN (rare), Fetal anemia
Lub—Malignancy, SCD, HDFN
How are Lewis and Secretor genes linked in the expression of Lewis antigens?
Inheritance pattern
3 Lewis phenotypes
Le(a+b-) inherit Le gene and 2 (se) gene—(nonsecretor)
Le(a-b+) inherit Le gene and at least 1 (Se) gene—(secretor)
2 (lele) genes give rise to La (a-b-)
What is the definition of a "clinically significant" antibody?
Antibodies that cause decreased survival of RBCs possessing the target antigen
Reagent red cells used for screening cells and antibody panels are group O, why?
Group O red cells do not react with Anti-A or Anti-B in patient's serum/plasma
What are the limitations to the antibody screen?
Will not detect antibodies when the antibody titer has dropped below detectable levels
Cannot detect antibodies against low prevalence antigens not present on screening cells
May not detect autoantibodies or drug induced antibodies
How does the patient history play a role in the antibody identification?
Patient history can show previously identified antibodies or the possibility of an antibody due to pregnancy, transfusion, or drug interactions
When interpreting panel results, what considerations should be made?
Reaction strength—do all cells react at the same strength
Phase of testing—do all reactions occur at the same reaction temperature or phase
Patterns—do the reactions match a pattern of a particular antibody
Are all commonly encountered, clinically significant antibodies ruled out
Explain the principles behind enzyme and neutralization techniques.
Enzymes—modify the RBCs surface by removing sialic acid resideues and by denaturing or removing glycoproteins. This results in some antibody reactions being destroyed and others can be enhanced
Destroyed: MNSs, Fya, Fyb, Kell
Enhanced: Rh, Kidd, Lewis, P1, I
Neutralization—Substances in the body and in nature have antigenic structures similar to certain RBC antigens and can consequently be used to neutralized the corresponding RBC antibodies in the patient serum for exclusion of the remaining antibodies
Anti-Lewis neutralized with plasma, serum, or saliva
Anti P1 and Anti-I can also be neutralized
Explain Adsorption techniques used in conjunction with panels for antibody ID.
Antibodies may be removed or adsorbed from serum by incubating the specimen with the corresponding antigen. Auto Adsorptions are most often used to remove and autoantibody from plasma so that it can then be tested for an underlying alloantibody (patient RBCs + patient Plasma) Homologous adsorptions use phenotypically matched reagent/donor red cells to remove a known alloantibody from the patient plasma so that it can be tested for any other antibodies which may be present
Explain high frequency and low frequency antigens.
High frequency antigens—commonly present on RBCs because most of the population carries the antigen >98%. 98/100 will have the antigen or their red cells i. e. little k (cellano) is a high frequency antigen at 98-99% frequency
Low frequency antigens—are not routinely present on RBCs because the antigens occur on less than 10% of the population. K (Kell) is a low frequency antigen at 9% frequency
State the definition and characteristics of HDN:
Destruction of the RBCs of the fetus and neonate by antibodies produced by the mother
Characteristics: low fetal/neonate hgb (anemia), elevated bilirubin
What type of prenatal testing is performed?
ABO/Rh, antibody screen
Why are antibody titers performed on pregnant women with clinically significant
An increase in the antibody titer ≥ 32 is in indication of possible fetal RBC Destruction. This test will be the screening test to see if further testing such as Amniocentesis is necessary
What testing is performed on the newborn infant to assess the baby for possible RBC destruction
DAT, RBC count, Hgb, Hct, Retic, bilirubin
How does ABO and Rh HDN differ?
ABO HDN
Present during first pregnancy
Disease is NOT monitored by titers
Normal Bilirubin at birth (elevates at 1-3 days)
No Anemia at birth
Phototherapy at birth
Rh HDN
Rare during first pregnancy
Disease IS monitored by titers
Elevated bilirubin at birth
Anemia IS at birth
Phototherapy at birth
What is CHD
Chronic or acute condition often associated with Mycoplasma pnaumoniae or infectious mono. The cold autoantibody reacts at RT or 4°C and is usually an Auto anti-I.
What is PCH
Most often occurs in children with viral diseases such as measles, mumps, chickenpox, mono or the flu
PCH is an IgG autoantibody also known as the DOnath-Landsteiner antibody, which is the test used to identify.
Biphasic hemolysin, meaning that it binds to RBCs at cold and then lyses the cells at 37°C.
IgG autoantibody with a specificity for the P antigen
How do you select blood for transfusion for a patient with a WAIHA?
Transfuse the least compatible units
When Crossmatching unit, you get varying degrees of reactivity, you will transfuse the units which have the weakest reactions
IHTR antibodies
A1, K, Jka, Fya
DHTR antibodies
Jka, Fya
HDFN common antibodies
A, D, C, E, k
Most frequently associated with severe HDFN
Anti-K
Associated with CAD and M. pneumoniae
Anti-I
IgM antibodies
M, N, P1, I/i, Lea, Leb, Lua
IgG antibodies
Rh, K/k, Fya, Fyb, Kidd, Lub